| Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET R La Joie, AV Visani, SL Baker, JA Brown, V Bourakova, J Cha, ... Science translational medicine 12 (524), eaau5732, 2020 | 428 | 2020 |
| 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes RM Tsai, A Bejanin, O Lesman-Segev, R LaJoie, A Visani, V Bourakova, ... Alzheimer's research & therapy 11, 1-18, 2019 | 148 | 2019 |
| Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample R La Joie, A Bejanin, AM Fagan, N Ayakta, SL Baker, V Bourakova, ... Neurology 90 (4), e282-e290, 2018 | 141 | 2018 |
| Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET R La Joie, AV Visani, OH Lesman-Segev, SL Baker, L Edwards, ... Neurology 96 (5), e650-e661, 2021 | 80 | 2021 |
| Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy OH Lesman-Segev, R La Joie, ML Stephens, I Sonni, R Tsai, ... NeuroImage: Clinical 24, 102025, 2019 | 64 | 2019 |
| Recognition of letters displayed as briefly flashed dot patterns E Greene, A Visani Attention, Perception, & Psychophysics 77, 1955-1969, 2015 | 51 | 2015 |
| Could vagus nerve stimulation target hippocampal hyperactivity to improve cognition in schizophrenia? J Smucny, A Visani, JR Tregellas Frontiers in Psychiatry 6, 135146, 2015 | 28 | 2015 |
| Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline Tau-PET. Sci Transl Med R La Joie, AV Visani, SL Baker, JA Brown, V Bourakova, J Cha, ... | 25 | 2020 |
| Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020; 12 R La Joie, AV Visani, SL Baker, JA Brown, V Bourakova, J Cha, ... Epub 2020/01/03. doi: 10.1126/scitranslmed. aau5732. PubMed PMID: 31894103, 0 | 13 | |
| F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. Alzheimers Res Ther. 2019; 11: 13 RM Tsai, A Bejanin, O Lesman-Segev, R LaJoie, A Visani, V Bourakova, ... | 5 | |
| [IC‐01–01]: AV1451‐PET CORTICAL UPTAKE AND REGIONAL DISTRIBUTION PREDICTS LONGITUDINAL ATROPHY IN ALZHEIMER's DISEASE R La Joie, A Visani, V Bourakova, SL Baker, N Ayakta, J Pham, ... Alzheimer's & Dementia 13 (7S_Part_1), P1-P1, 2017 | 4 | 2017 |
| Colocalization of atrophy and tau improves AI classification of Alzheimer phenotypical variants: Tau imaging PF Damasceno, R La Joie, PD Maia, A Visani, L Iaccarino, A Strom, ... Alzheimer's & Dementia 16, e046258, 2020 | 2 | 2020 |
| P1‐452: MODELING AMYLOID, TAU, AND NEURODEGENERATION ACROSS THE ALZHEIMER'S DISEASE SPECTRUM: CROSS‐SECTIONAL STUDY J Cha, YH Park, JM Lee, SL Baker, A Visani, V Bourakova, J Pham, ... Alzheimer's & Dementia 14 (7S_Part_9), P489-P489, 2018 | 1 | 2018 |
| A case of TUBB4A-related hypomyelinating leukodystrophy with abnormal movements responsive to levodopa/carbidopa (4682) A Visani, S Ahmadi, M Mwangi Neurology 96 (15 Supplement), 2021 | | 2021 |
| How ‘atypical’is the neuroimaging signature of Alzheimer’s atypical variants? MRI and PET imaging of posterior cortical atrophy and logopenic variant of primary progressive … RL Joie, PF Damasceno, A Visani, L Iaccarino, A Strom, L Edwards, ... Alzheimer's & Dementia 16, e040623, 2020 | | 2020 |
| Colocalization of atrophy and tau improves AI classification of Alzheimer phenotypical variants PF Damasceno, R La Joie, PD Maia, A Visani, L Iaccarino, A Strom, ... 2020 Alzheimer's Association International Conference, 2020 | | 2020 |
| IC‐P‐136: MODELING AMYLOID, TAU, AND NEURODEGENERATION ACROSS THE ALZHEIMER'S DISEASE SPECTRUM: CROSS‐SECTIONAL STUDY J Cha, YH Park, JM Lee, SL Baker, A Visani, V Bourakova, J Pham, ... Alzheimer's & Dementia 14 (7S_Part_2), P113-P115, 2018 | | 2018 |
| IC‐P‐145: NON‐AMNESTIC PHENOTYPES OF ALZHEIMER'S DISEASE, EARLY AGE OF ONSET AND APOE GENOTYPE ARE ASSOCIATED WITH TAU, NOT Aβ‐PET R La Joie, A Visani, OH Lesman-Segev, V Bourakova, SL Baker, ... Alzheimer's & Dementia 14 (7S_Part_2), P123-P124, 2018 | | 2018 |
| P2‐335: ASSESSING PATIENT HEALTH RISK FACTOR BURDEN AND APOE IN SPORADIC EARLY‐ONSET AD WITH AND WITHOUT AD FAMILY HISTORY V Bourakova, J Taylor, R La Joie, A Visani, OH Lesman-Segev, ... Alzheimer's & Dementia 14 (7S_Part_15), P811-P812, 2018 | | 2018 |
| P3‐415: PATIENT‐TAILORED PREDICTIONS OF GRAY MATTER ATROPHY IN ALZHEIMER'S DISEASE BASED ON BASELINE FLORTAUCIPIR AND CONNECTOME‐BASED SPREAD J Brown, R La Joie, A Visani, HJ Rosen, BL Miller, WJ Jagust, WW Seeley, ... Alzheimer's & Dementia 14 (7S_Part_23), P1265-P1266, 2018 | | 2018 |
